| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.004 |